Acerca de Cardihab

Acerca de la compañía

Cardihab provides clinicians with the ability to remotely deliver a scientifically validated, comprehensive Phase 2 CR program based on ACRA guidelines. In a world first randomised controlled trial, CSIRO & Queensland Health researchers demonstrated that remote delivery of CR improves patient uptake (+29%), adherence (+38%) and completion (+70%) while significantly reducing the number of centre visits (-86%) and delivering equivalent clinical outcomes when compared to traditional, centre-based Phase 2 rehab program.